ArticleExperimental & molecular medicine2024

Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disorders.

Htoo A Wai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.